Trial intelligence / Profile preview

Linezolid vs Vancomycin in Febrile Neutropenia

NCT00035425Phase 3Completed

Sponsor
Pfizer
Start
Nov 2001
Modality
Small Molecules
Countries
10
01

Overview

A Phase 3 trial of linezolid in febrile neutropenia (FN), sponsored by Pfizer. Started Nov 2001; status: completed.

02

Drugs

linezolid
03

Conditions

febrile neutropenia (FN)

Beyond the preview

Go deeper on NCT00035425.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00035425.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call